"I love Improving Patients' Lives | Jazz Pharmaceuticals"

2022-05-10 15:28:46

Contact UsAboutLeadershipBoard of DirectorsGlobal FootprintAustralia and New ZealandCanadaFranceGermany and AustriaUnited Kingdom and IrelandItalySpain and PortugalNordic RegionUnited StatesCountries Supplied through PartnersHistoryCorporate ValuesCorporate DevelopmentPartneringManufacturingVilla Guardia, Italy (Gentium S.r.l)Athlone, Ireland (Jazz Pharmaceuticals Ireland Limited)MedicinesOur MedicinesDrug SafetyMedical Information USMedical Information Outside of the USSciencePipelineClinical TrialsGW Cannabinoid PlatformExpanded AccessIndependent Scientific ResearchClinical Trial TransparencyClinical Trial Data SharingPlain Language SummariesOur PurposePatient SupportCorporate GivingPatient ResourcesEnvironmental, Social, Governance and DisclosuresEthical StandardsMedical EducationFellowshipsTransfers of Value in EuropeNewsPress Release ArchiveEvents ArchiveOur StoriesCompany AnnouncementsPatient StoriesScience StoriesPerspectivesInvestorsEvents / PresentationsFinancialsSEC FilingsQuarterly ResultsAnnual ReportsPipelineStock InformationESGResourcesFAQsEmail AlertsInformation RequestAnalyst CoverageOther InformationCareers Transforming Lives.Redefining Possibilities.PerspectivesHonoring 2022 Women’s History Month and International Women’s DayWe celebrated International Women’s Day and Women’s History Month with awareness-building events and engaging sessions with our Jazz Association of Women Supporters (JAWs) employee-led Affinity Forum, including a very special event for our employees featuring Brooke Baldwin, award-winning journalist and author of the book, Huddle: How Women Unlock Their Collective Power. After hearing from Brooke and having a rich dialogue, we closed out our Women’s History Month event with the announcement of distinguished recognition for two of our Jazz colleagues by the Healthcare Businesswomen’s Association (HBA) as 2022 honorees in the healthcare industry.Learn MorePerspectivesDiscussing the Importance of Lowering Sodium for Narcolepsy PatientsAt Jazz, we push ourselves and other stakeholders to think holistically about patients’ health to minimize the risk of patient co-morbidities and address significant unmet needs. To learn more about the often-overlooked co-morbidities associated with narcolepsy and the progress Jazz has made to address them, Jazz’s Dr. Todd Kirby spoke with sleep specialist Dr. Richard K. Bogan.Learn MoreNews and EventsFebruary 2, 2022Jazz Pharmaceuticals Completes U.S. FDA Supplemental Biologics License Application for Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Monday/Wednesday/Friday Dosing ScheduleJanuary 10, 2022Jazz Pharmaceuticals Announces Vision 2025 to Deliver Sustainable Growth and Enhanced Value to Drive Transformation to Innovative, Global Biopharmaceutical LeaderJanuary 5, 2022Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic HypersomniaJanuary 3, 2022Jazz Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare ConferenceSee all NewsJazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.More About JazzLiving Our ValuesCareers at JazzClinical TrialsLearn MoreBy unlocking biopharmaceutical discoveries to develop novel medicines, we are giving thousands of people around the world the opportunity to redefine what’s possible.Our Medicines AboutLeadershipBoard of DirectorsGlobal FootprintHistoryCorporate ValuesCorporate DevelopmentManufacturingNewsOur StoriesCareersMedicinesOur MedicinesDrug SafetyMedical Information USMedical InformationOutside of the USSciencePipelineClinical TrialsExpanded AccessIndependent Scientific ResearchOur PurposePatient SupportCorporate GivingPatient ResourcesEnvironmental, Social, Governance and DisclosuresEthical StandardsMedical EducationTransfers of Value in EuropeInvestorsEvents / PresentationsStock InformationSEC FilingsGAAP To Non-GAAP ReconciliationsAnnual ReportsQuarterly ResultsAnalyst CoverageInformation RequestFAQsOther Information© 2022 Jazz Pharmaceuticals, Inc. All Rights Reserved.Privacy StatementTerms of UseSocial Media Global GuidelinesCookie PolicySitemap The information on this page is intended for visitors in Continue This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident. Continue You are leaving the Home page Leave You are leaving the Home page Leave Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue. Ok Cancel You are now leaving www.JazzPharma.com. Thank you for visiting. The information on the website you are entering is intended for visitors in the United States only. Ok Cancel